Microdialysis studies of basal levels and stimulus-evoked overflow of dopamine and metabolites in the striatum of young and aged Fischer 344 rats

Brain Research

Volumn 816, Issue 1, 1999, Pages 68-77

  Gerhardt, Greg A ^a   Maloney Jr , Ronald E ^b  

^a Neuroscience Program   (United States)

^b LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

Aging; Basal level; D Amphetamine; Dopamine; Fischer 344 rat; Intracranial microdialysis; Potassium; Striatum

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; DEXAMPHETAMINE; DOPAMINE; HOMOVANILLIC ACID; POTASSIUM; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; ELECTROCHEMICAL DETECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SENESCENCE;

3,4-DIHYDROXYPHENYLACETIC ACID; AGING; ANALYSIS OF VARIANCE; ANIMALS; CORPUS STRIATUM; DEXTROAMPHETAMINE; DOPAMINE; EXTRACELLULAR SPACE; HOMOVANILLIC ACID; HYDROXYINDOLEACETIC ACID; MALE; MICRODIALYSIS; POTASSIUM; RATS; RATS, INBRED F344;

EID: 0033573716     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)01095-6     Document Type: Article

References (49)

1. Bennett D.A., Beckett L.A., Murray A.M., Shannon K.M., Goetz C.G., Pilgrim D.M., Evans D.A. Prevalence of parkinsonian signs and associated mortality in a community population of older people. New Engl. J. Med. 334:1996;71-76.
2. Burwell R.D., Lawler C.P., Gallagher M. Mesostriatal dopamine markers in aged Long-Evans rats with sensorimotor impairment. Neurobiol. Aging. 16:1995;175-186.
3. Cass W.A., Gerhardt G.A., Gillespie K., Curella P., Mayfield R.D., Zahniser N.R. Reduced clearance of exogenous dopamine in rat nucleus accumbens, but not in dorsal striatum, following cocaine challenge in rats withdrawn from repeated cocaine administration. J. Neurochem. 61:1993;272-283.
4. Cass W.A., Zahniser N.R., Flach K.A., Gerhardt G.A. Clearance of exogenous dopamine in rat dorsal striatum and nucleus accumbens: role of metabolism and effects of locally applied uptake inhibitors. J. Neurochem. 61:1993;2269-2278.
5. Dluzen D.E., McDermott J.L., Ramirez V.D. Changes in dopamine release in vitro from the corpus striatum of young versus aged rats as a function of infusion modes of L-DOPA, potassium, and amphetamine. Exp. Neurol. 112:1991;153-160.
6. W.S. Fields, W.D. Willis, The Cerebellum in Health and Disease, Warren H. Green, St. Louis, MO, 1970.
7. Friedemann M.N. In vivo electrochemical studies of dopamine diffusion and clearance in the striatum of young and aged Fischer 344 rats. Age. 15:1992;23-26.
8. Friedemann M.N., Gerhardt G.A. Regional effects of aging on dopaminergic function in the Fischer 344 rat. Neurobiol. Aging. 13:1992;325-332.
9. Gerhardt G.A., Cass W.A., Henson M., Zhang Z., Ovadia A., Hoffer B.J., Gash D.M. Age-related changes in potassium-evoked overflow of dopamine in the striatum of the rhesus monkey. Neurobiol. Aging. 16:1995;939-946.
10. Giros B., Jaber M., Jones S.R., Wightman R.M., Caron M.G. Hyperlocomotion and indifferences to cocaine and amphetamine in mice lacking the dopamine transporter. Nature. 379:1996;606-612.
11. Goudsmit E., Feenstra M.G.P., Swaab D.F. Central monoamine metabolism in the male Brown-Norway rat in relation to aging and testosterone. Brain Res. Bull. 25:1990;755-763.
12. Gozlan H.G., Daval, Verge D., Spampinato U., Fattaccini C.M., Gallissot M.C., Mestikawy S., Hamon M. Aging associated changes in serotonergic and dopaminergic pre- and post-synaptic neurochemical markers in the rat brain. Neurobiol. Aging. 11:1990;437-449.
13. 3H ]dopamine release from median eminence and striatal synaptosomes during aging Endocrinology. 126:1990;228-234.
14. Hadfield M.G., Milio C. Regional brain monoamine levels and utilization in middle-aged rats. Life Sciences. 46:1987;295-299.
15. Hall M.E., Hoffer B.J., Gerhardt G.A. Rapid and sensitive determination of catecholamines in small tissue samples by high pressure liquid chromatography coupled with dual-electrode coulometric electrochemical detection. LC/GC. 7:1989;258-265.
16. Hebert M.A., Gerhardt G.A. Normal and drug-induced locomotor behavior in aging: comparison to evoked DA release and tissue content in Fischer 344 rats. Brain Res. 797:1998;42-54.
17. Hornykiewicz O., Kish S.J. Biochemical pathophysiology of Parkinson's disease. Advances in Neurology. 45:1987;19-34.
18. Ingram D.K., Joseph J.A., Spangler E.L., Roberts D., Hengemihle J., Fanelli R.J. Chronic nimodipine treatment in aged rats: analysis of motor cognitive effects and muscarinic-induced striatal dopamine release. Neurobiol. Aging. 15:1994;55-61.
19. Jones S.R., Gainetdinov R.R., Wightman R.M., Caron M.G. Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J. Neurosci. 18(6):1998;1979-1986.
20. +-evoked release of endogenous striatal dopamine: an indicator of altered cholinergic-dopaminergic reciprocal inhibitory control in senescence. Brain Res. 454:1988;140-148.
21. Joyce J.N., Loeschen S.K., Sapp D.W., Marshall J.F. Age-related regional loss of caudate-putamen dopamine receptors revealed by quantitative autoradiography. Brain Res. 378:1986;158-163.
22. Kametani H., Iijima S., Spangler E.L., Ingram D.K., Joseph J.A. In vivo assessment of striatal dopamine release in the aged male Fischer 344 rat. Neurobiol. Aging. 16:1995;639-646.
23. Leenders K.L., Salmon E.P., Tyrrell P., Perani D., Brooks D.J., Sager H., Jones T., Marsden C.D., Frackowiak S.J. The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease. Arch. Neurol. 47:1990;1290-1298.
24. Marshall J.F., Berrios N. Movement disorders of aged rats: reversal by dopamine receptor stimulation. Science. 206:1979;477-479.
25. Marshall J.F., Altar C.A. Striatal dopamine uptake and swim performance of the aged rat. Brain Res. 379:1986;112-117.
26. Marshall J.F., Rosenstein A.J. Age-related decline in rat striatal dopamine metabolism is regionally homogeneous. Neurobiol. Aging. 11:1990;131-137.
27. McIntosh H.H., Westfall T.C. Influence of aging on catecholamine levels, accumulation, and release in F-344 rats. Neurobiol. Aging. 8:1987;233-239.
28. Menacherry S., Hubert W., Justice J.B. Jr. In vivo calibration of microdialysis probes for exogenous compounds. Anal. Chem. 64-66:1992;577-583.
29. Missalle C., Govoni S., Pasinetti G. C.A, Assini C., Spano P.F., Battaini F., Trabucchi M. Age-dependent changes in the mechanisms regulating dopamine uptake in the central nervous system. J. Gerontol. 41:1986;136-139.
30. Moretti A.N., Carfagna, Trunzo F. Effect of aging on monoamines and their metabolites in the rat brain. Neurochem. Res. 12:1987;1035-1039.
31. Morrison J.H., Hof P.R. Life and death of neurons in the aging brain. Science. 278:1997;412-419.
32. J.A. Mortimer, D.D. Webster, Comparison of extrapyramidal motor function in normal aging and Parkinson's disease, in: J.A. Mortimer, F.J. Pirozzola, G.J. Maletta (Eds.), The Aging Motor System, Praeger, New York, 1982, pp. 217-241.
33. Nakano M., Mizuno T. Age-related changes in the metabolism of neurotransmitters in rat striatum: a microdialysis study. Mechanisms of Ageing and Development. 86:1996;95-104.
34. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, Academic Press, New York, 1986.
35. Rose G., Gerhardt G., Stromberg I., Olson L., Hoffer B. Monoamine release from dopamine-depleted rat caudate nucleus reinnervated by substantia nigra transplants: an in vivo electrochemical study. Brain Res. 341:1985;92-100.
36. Rose G.M., Gerhardt G.A., Conboy G.L., Hoffer B.J. Age-related alterations in monoamine release from rat striatum: an in vivo electrochemical study. Neurobiol. Aging. 7:1986;77-82.
37. Santiago, Machado A., Cano J. Effects of age and dopamine agonists and antagonists on striatal dopamine release in the rat: an in vivo microdialysis study. Mechanisms of Ageing and Development. 67:1993;261-267.
38. 3H ]dopamine uptake in rat striatum during aging J. Neurochem. 56:1991;575-579.
39. Stamford J.A. Development and aging of the rat nigrostriatal dopamine system studied with fast cyclic voltammetry. J. Neurochem. 52:1989;1582-1589.
40. Strong R., Samorajski T., Gottesfeld Z. Regional mapping of neostriatal neurotransmitter systems as a function of aging. J. Neurochem. 39:1982;831-836.
41. Strong R., Samorajski T., Gottesfeld Z. High-affinity uptake of neurotransmitters in rat neostriatum: effects of aging. J. Neurochem. 43:1984;1766-1768.
42. van Horne C., Hoffer B.J., Stromberg I., Gerhardt G.A. Clearance and diffusion of locally applied dopamine in normal and 6-hydroxydopamine-lesioned rat striatum. J. Pharmacol. Exp. Ther. 263:1992;1285-1292.
43. Watanabe H. Differential decrease in the rate of dopamine synthesis in several dopaminergic neurons of aged rat brain. Exp. Gerontol. 22:1987;17-25.
44. A.T. Welford, Motor performance, in: J.E. Birren, K.W. Schaie (Eds.), Handbook of the Psychology of Aging, Van Nostrand-Reinhold, New York, 1977, pp. 450-497.
45. Yamagami K., Joseph J.A., Roth G.S. Muscarinic receptor concentrations and dopamine release in aged rat striata. Neurobiol. Aging. 13:1991;51-56.
46. Yurek D.M., Hipkens S.B., Hebert M.A., Gash D.M., Gerhardt G.A. Age-related decline in striatal dopamine release and motoric function in Brown Norway/Fischer 344 hybrid rats. Brain Res. 791:1998;246-256.
47. Zetterstrom T., Sharp T., Marsden C.A., Ungerstedt U. In vivo measurements of dopamine and its metabolites by intracerebral dialysis: changes after D-amphetamine. J. Neurochem. 41:1983;1769-1773.
48. Zigmond M.J., Acheson A.L., Stachowiak M.K., Stricker E.M. Neurochemical compensation after nigrostriatal injury in an animal model of preclinical parkinsonism. Arch. Neurol. 41:1984;856-861.
49. Zigmond M.J., Abercrombie E.D., Berger T.W., Grace A.A., Stricker E.M. Compensations after lesions of central dopaminergic neurons: some clinical and basic implications. Trends Neurosci. 12:1990;290-296.